Catalyst Health Ventures

Catalyst Health Ventures (CHV) is a well-established Boston-based venture capital firm with a clear focus on early-stage healthcare innovation. Since its inception in 2000, CHV has dedicated its efforts to identifying and funding disruptive solutions that address significant unmet needs within the healthcare sector. The firm primarily targets companies in the medical device, diagnostics, and digital health spaces, seeking out promising ventures poised to transform patient care and industry practices.

CHV's investment strategy centers on providing crucial early-stage capital, typically participating in Seed and Series A funding rounds. Their initial investments generally fall within a range of $1 million to $5 million, reflecting their commitment to supporting nascent companies through their critical initial growth phases. Beyond the initial cheque, Catalyst Health Ventures is known for reserving substantial capital for follow-on investments, demonstrating a long-term commitment to their portfolio companies' success and growth trajectory.

The firm boasts a robust track record, having invested in over 40 companies since its founding. This extensive portfolio underscores CHV's deep experience and network within the healthcare industry. Furthermore, their strategic support and guidance have enabled their portfolio companies to collectively secure over $1.5 billion in follow-on capital from other leading healthcare investors, highlighting CHV's ability to identify and nurture ventures that attract significant further investment and achieve substantial milestones. As an active participant in the vibrant Boston healthcare ecosystem, CHV continues to be a key player in fostering innovation in the sector.